Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.
暂无分享,去创建一个
P. Libby | M. Sabatine | E. Braunwald | C. Cannon | D. Morrow | C. McCabe | D. Simon | K. Croce | A. Pradhan | Yunmei Wang | Huiyun Gao | M. Sakuma | J. Buros | A. Healy | C. Mccabe
[1] P. Libby,et al. Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events , 2006, Circulation.
[2] C. Cannon,et al. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. , 2005, Journal of the American College of Cardiology.
[3] K. Swoboda,et al. Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.
[4] M. Pfeffer,et al. C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.
[5] I. Thorey,et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. , 2004, Blood.
[6] K. Clauser,et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[7] H. Drexhage,et al. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. , 2004, Diabetes.
[8] C. Heeschen,et al. Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes , 2003, Circulation.
[9] P. Libby,et al. Soluble CD40L: Risk Prediction After Acute Coronary Syndromes , 2003, Circulation.
[10] David A Morrow,et al. Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy , 2003, Circulation.
[11] F. Crea,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[12] W. Nacken,et al. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity , 2003, Microscopy research and technique.
[13] R. Donato,et al. Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.
[14] P. Libby,et al. Inflammation and thrombosis: the clot thickens. , 2001, Circulation.
[15] C. Sorg,et al. Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice. , 2000, Atherosclerosis.
[16] M. Neurath,et al. RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.
[17] N. Hogg,et al. Signaling mechanisms and the activation of leukocyte integrins , 1997, Journal of leukocyte biology.
[18] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[19] M J Davies,et al. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.
[20] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[21] C. Bauters,et al. [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.
[22] Michael Miller. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.